InsidersTradesSigma
Track the Corline Biomedical AB stock price and the full insider trade history of the company, a publicly traded company based in Finland. Shares are listed on FI FI, under the supervision of FIN-FSA. Operating in the Health Care sector, Corline Biomedical AB has logged 1 insider filings. Market capitalisation: €467.8m. The latest transaction was filed on 18 November 2025 (Purchase). Among the most active insiders: Henrik Nittmar. All data is openly available.
Analysts rate Corline Biomedical AB Strong Buy (bullish), based on 1 analysts. Average price target: SEK 29.00.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration